Quick Answer
VOLITIONRX LTD reported Net Income Loss of -$23.36 million for the year ending 2025.
- VOLITIONRX LTD showed an increase of +13.4% in Net Income Loss from 2024 to 2025.
- This data is from VOLITIONRX LTD's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), VOLITIONRX LTD's Net Income Loss has declined by 795.4%.
- Historical annual values: Fiscal year 2025: -$23.36 million | Fiscal year 2024: -$26.97 million | Fiscal year 2023: -$35.68 million | Fiscal year 2022: -$30.60 million | Fiscal year 2021: -$26.99 million | Fiscal year 2020: -$20.40 million | Fiscal year 2019: -$16.10 million | Fiscal year 2018: -$18.01 million | Fiscal year 2017: -$14.77 million | Fiscal year 2016: -$11.91 million | Fiscal year 2015: -$9.53 million | Fiscal year 2014: -$8.21 million | Fiscal year 2013: -$3.71 million | Fiscal year 2012: -$4.08 million | Fiscal year 2011: -$2.61 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: